Have a personal or library account? Click to login
Penetrance of CHEK2 and BRCA1 Double Heterozygotes in Breast and/or Ovarian Cancer Patients Cover

Penetrance of CHEK2 and BRCA1 Double Heterozygotes in Breast and/or Ovarian Cancer Patients

Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
Volume 77 (2023): Issue 2 (April 2023)
By: Egija Berga-Švītiņa,  Valdis Pirsko,  Miki Nakazawa-Miklaševiča,  Jeļena Maksimenko,  Jānis Gardovskis and  Edvīns Miklaševičs  
Open Access
|May 2023
DOI: https://doi.org/10.2478/prolas-2023-0020 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Journal RSS Feed
Language: English
Page range: 137 - 140
Submitted on: Nov 1, 2021
|
Accepted on: Feb 8, 2023
|
Published on: May 18, 2023
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
pathogenic variant carriers,
breast cancer,
double heterozygote,
ovarian cancer
Related subjects:
General interest,
Mathematics,
General mathematics

© 2023 Egija Berga-Švītiņa, Valdis Pirsko, Miki Nakazawa-Miklaševiča, Jeļena Maksimenko, Jānis Gardovskis, Edvīns Miklaševičs, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 77 (2023): Issue 2 (April 2023)